Stimufend Alternatives Compared
| Stimufend (pegfilgrastim) | Cefepime | Amoxicillin / clavulanate |
|
|---|
| Stimufend (pegfilgrastim) | Cefepime | Amoxicillin / clavulanate |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Neutropenia Associated with Chemotherapy, Febrile Neutropenia, Neutropenia Associated with Radiation, Hematopoietic Syndrome of Acute Radiation Syndrome. Stimufend may also be used for... View more |
Prescription only
Prescribed for Kidney Infections, Febrile Neutropenia, Intraabdominal Infection, Bacteremia, Nosocomial Pneumonia, Pneumonia, Skin and Structure Infection, Skin or Soft Tissue Infection, Urinary... View more |
Prescription only
Amoxicillin/clavulanate is a combination penicillin-type antibiotic that should be reserved for the treatment of infections caused by susceptible beta-lactamase-producing bacteria. Its use may be... View more |
Related suggestions Febrile Neutropenia
|
|||||||||||||||||||||||
| More about Stimufend (pegfilgrastim) | More about Cefepime | More about Amoxicillin / clavulanate | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Be the first to share your experience with this drug. |
Cefepime has an average rating of 8.0 out of 10 from a total of 5 ratings on Drugs.com. 60% of reviewers reported a positive effect, while 0% reported a negative effect. |
Amoxicillin / clavulanate has an average rating of 5.3 out of 10 from a total of 913 ratings on Drugs.com. 39% of reviewers reported a positive effect, while 41% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all Stimufend side effects |
View all Cefepime side effects |
|
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
N/A |
Lower cost generic |
Lower cost generic |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Stimufend prices |
View all Cefepime prices |
View all Amoxicillin / clavulanate prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Other pegfilgrastim brands include: Fulphila, Fylnetra, Neulasta, Nyvepria, Udenyca, Ziextenzo |
N/A |
Amoclan, Augmentin, Augmentin XR | ||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
80 hours |
N/A |
1.7 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 178 drugs are known to interact with Stimufend:
|
A total of 56 drugs are known to interact with Cefepime:
|
A total of 97 drugs are known to interact with Amoxicillin / clavulanate:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
N/A |
January 18, 1996 |
August 06, 1984 |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.